AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca. 

Our vision “Health for All – Hunger for None”

Advancing life – that’s what we at Bayer are all about. We put ourselves to the test day in, day out. All together. All over the world. With enthusiasm for new ideas.

Bayer is a Life Science company with a more than 150-year history of Innovation and core competencies in the areas of health care and agriculture. Thus, we are in the unique position to provide solutions that serve our most basic human needs – health and food.

Bayer Hellas is the subsidiary of Bayer AG in our country. Our company is operating since 1955, in researching, developing and marketing the locally approved products of Bayer AG, in all the three divisions.

At Bristol Myers Squibb, we believe in the power of science to address some of the most challenging diseases of our time. Our focus on these unmet needs comes during a remarkable time, when unprecedented scientific breakthroughs are advancing the treatment of disease as never before in human history.

We work every day to transform patients’ lives through science. Each day, our employees around the world work together for patients – they are at the center of everything we do. They inspire us. They are the reason we come to work each day. We combine the agility of a biotech with the reach and resources of an established pharmaceutical company to create a global leading biopharma company powered by talented individuals who drive scientific innovation.

We are proud of the advancements we have made in oncology, hematology, immunology and cardiovascular disease, and we are dedicated to helping patients prevail over serious diseases through our diverse and promising pipeline and new scientific platforms.

At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. 

We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension. 

Learn more at www.janssen.com, www.janssen.com/greece/.

Follow us at www.twitter.com/JanssenGlobal , www.linkedin.com/showcase/janssengreece/.

Janssen-Cilag Pharmaceutical S.A.C.I. is one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Consistently investing in research and development  

ELPEN has been active since 1965 in the production of branded Greek medicines. With 1,100 employees at group level, the company invests more than 10% of its annual turnover in research projects. With exports of 30 medicinal products and an active presence in 18 European countries and 41 worldwide, is recognized in international markets. 

ELPEN has launched a 5 years investment plan of 125 million €. This includes the construction of a new production plant in Keratea and a Research and Innovation Park in Spata, as well as the modernization of its existing production facilities in Pikermi.  

The Institute of Pharmaceutical Research and Technology is a subsidiary of the National Organization for Medicines. It mainly engages in the production, import and distribution of pharmaceutical products, which are not marketed in Greece by private pharmaceutical companies and are deemed indispensable for patient treatment and the protection of public health.   

The Institute’s mission is to make healthcare available to all patients, by providing solutions that enable access to products, therapies, and technology. Its priority lies with patients, and the coverage of their needs in an integrated and responsible way, with respect to the applicable legislation, regulations, and international standards. For the past 30 years, the Institute has been focusing on the Greek patient, working consistently and persistently for the protection of Public Health, ensuring access to rare medicines and treatments, while offering top health services, innovating, and evolving. 

CONEQ provides technical equipment and services to any kind of event. With our Simultaneous Interpretation Systems, Conference Systems, AudioVisual Equipment we support events and provide the best service to our customers. Our professionalism, our high quality of service and state of the art equipment offered to over 600 large and of great significance conferences during the last 5 years have certainly contributed to our constant uptrend. Call us at (+30) 211 2163453. or email us at [email protected]

Affidea is the largest provider of Primary Health Care services in Europe with activity in 15 countries. In Greece Affidea started its operation in 2005 with the aim to provide high quality health services to everyone. Affidea centers are certified according to the international standard ISO 9001 and the biopathological laboratories are accredited by the National Accreditation System (ESS) according to ISO 15189. Today Affidea operates via a nationwide network of diagnostic centers with premium medical standards, state-of-the-art equipment and highly trained medical staff doctors.

IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients. Solutions are powered by the IQVIA CORE™, which combines big data, advanced technology, analytics and extensive industry knowledge. Formed through the merger of IMS Health and Quintiles, IQVIA has approximately 70,000 employees worldwide. Learn more at iqvia.com.

KALTEQ SA with 20-year of presence in the Greek & Cypriot Market is continuously growing and stands out as a strong partner.

KALTEQ SA portfolio includes a huge variety of high standards medical products and instruments for General & Laparoscopic Surgery, Cardiac Surgery, Neurosurgery, Neuroradiology, Chronic Pain, ENT, Home Healthcare, etc.

KALTEQ SA has main offices in Athens and branches in Thessaloniki, Heraklion, Patras and Nicosia and is also active in the countries of Southeast Europe and Balkans.

Takeda is the largest pharmaceutical company in Japan and has a strong presence in over 80 geographies across the world. With a history for over two and a half centuries, we focus on innovations that contribute to making a difference in people’s lives in our core therapeutic and business areas, including gastroenterology and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines.